Market Overview

Why Qiagen's Stock Is Trading Higher Today

Why Qiagen's Stock Is Trading Higher Today

Qiagen NV (NYSE: QGEN) shares are trading higher on Friday after Deutsche Bank upgraded the stock from Hold to Buy and raised its price target on the stock from $32 to $60 per share.

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences (52% of 2019 sales) and molecular diagnostics (48% of sales).

Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (47%), followed by EMEA (32%) and Asia-Pacific (21%).

Qiagen shares were trading up 2.77% at $50.02 on Friday at the time of publication. The stock has a 52-week high of $50.97 and a 52-week low of $25.04.

Latest Ratings for QGEN

Sep 2020Kepler CheuvreuxUpgradesHoldBuy
Aug 2020CommerzbankUpgradesHoldBuy
Aug 2020CitigroupUpgradesNeutralBuy

View More Analyst Ratings for QGEN
View the Latest Analyst Ratings


Related Articles (QGEN)

View Comments and Join the Discussion!

Posted-In: why it's movingUpgrades Analyst Ratings

Latest Ratings

STOKNeedhamInitiates Coverage On42.0
BMRCJanney CapitalUpgrades33.0
CLBABN AmroUpgrades
CRMDJMP SecuritiesInitiates Coverage On22.0
CXDOB. Riley FBRInitiates Coverage On8.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at